Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Sophie Jegouic Goodall

Vaccine Technology Development Scientist

I’m a virologist with over 10 years of experience in molecular biology, vaccine development, and diagnostics. I completed my PhD in Virology at the Institut Pasteur and Université Pierre et Marie Curie in Paris, where I studied viral recombination.

Following postdoctoral roles in the UK, I joined the University of Reading to work on diagnostics for diseases such as Dengue, COVID-19, and CCHFV, and contributed to a major Foot-and-Mouth Disease vaccine project in partnership with MSD Animal Health, The Pirbright Institute, and the University of Oxford.

I now work in Professor Dame Sarah Gilbert’s group at the University of Oxford, developing next-generation adenoviral vectors for multi-antigen vaccine delivery, with a focus on manufacturability and pandemic preparedness. In 2025, I completed the LifeArc Knowledge Transfer Fellowship, gaining training in IP and innovation to help bridge academic research with real-world solutions in global health.